Epidermal overexpression of granulocyte-macrophage colony-stimulating factor induces both keratinocyte proliferation and apoptosis

Cell Growth and Differentiation

Volumn 11, Issue 2, 2000, Pages 111-121

  Breuhahn, Kai ^a   Mann, Amrit ^a   Müller, Gabriele ^a   Wilhelmi, Arnd ^a   Schirmacher, Peter ^a   Enk, Alexander ^a   Blessing, Manfred ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; EPIDERMIS; KERATINOCYTE; LANGERHANS CELL; MAST CELL; MITOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL COUNT; CELL DIVISION; EPIDERMIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; KERATINOCYTES; KERATINS; LANGERHANS CELLS; MAST CELLS; MICE; MICE, TRANSGENIC; PHENOTYPE; RECOMBINANT FUSION PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0034012057     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Nishijima, I., Nakahata, T., Hirabayashi, Y., Inoue, T., Kurata, H., Miyajima, A., Hayashi, N., Iwakura, Y., Arai, K., and Yokota, T. A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF. Mol. Biol. Cell, 6: 497-508, 1995.
2. Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., and Banchereau, J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα. J. Exp. Med., 184: 695-706, 1996.
3. Dibbert, B., Daigle, I., Braun, D., Schranz, C., Weber, M., Blaser, K., Zangemeister-Wittke, U., Akbar, A. N., and Simon, H. U. Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood, 92: 778-783, 1998.
4. Kupper, T. S., Lee, F., Coleman, D., Chodakewitz, J., Flood, P., and Horowitz, M. Keratinocyte derived T-cell growth factor (KTGF) is identical to granulocyte macrophage colony stimulating factor (GM-CSF). J. Investig. Dermatol., 91: 185-188, 1988.
5. Braunstein, S., Kaplan, G., Gottlieb, A. B., Schwartz, M., Walsh, G., Abalos, R. M., Fajardo, T. T., Guido, L. S., and Krueger, J. G. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J. Investig. Dermatol., 103: 601-604, 1994.
6. Robertson, F. M., Bijur, G. N., Oberyszyn, A. S., Pellegrini, A. E., Boros, L. G., Sabourin, C. L., and Oberyszyn, T. M. Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion. Carcinogenesis (Lond.), 15: 1017-1029, 1994.
7. Pastore, S., Fanales-Belasio, E., Albanesi, C., Chinni, L. M., Giannetti, A., and Girolomoni, G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J. Clin. Investig., 99: 3009-3017, 1997.
8. Vasunia, K. B., Miller, M. L., Puga, A., and Baxter, C. S. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal dark cell numbers. Carcinogenesis (Lond.), 15: 653-660, 1994.
9. Kaplan, G., Walsh, G., Guido, L. S., Meyn, P., Burkhardt, R. A., Abalos, R. M., Barker, J., Frindt, P. A., Fajardo, T. T., Celona, R., et al. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J. Exp. Med., 175: 1717-1728, 1992.
10. Xing, Z., Gauldie, J., Tremblay, G. M., Hewlett, B. R., and Addison, C. Intradermal transgenic expression of granulocyte-macrophage colony-stimulating factor induces neutrophilia, epidermal hyperplasia. Langerhans' cell/macrophage accumulation, and dermal fibrosis. Lab. Investig., 77: 615-622, 1997.
11. Caux, C., Dezutter-Dambuyant, C., Schmitt, D., and Banchereau, J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature (Lond.), 360: 258-261, 1992.
12. Bratton, D. L., Hamid, Q., Boguniewicz, M., Doherty, D. E., Kailey, J. M., and Leung, D. Y. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J. Clin. Investig., 95: 211-218, 1995.
13. Leung, D. Y. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin. Exp. Immunol., 107: 25-30, 1997.
14. Rodriguez-Villanueva, J., Greenhalgh, D., Wang, X. J., Bundman, D., Cho, S., Delehedde, M., Roop, D., and McDonnell, T. J. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation. Oncogene, 16: 853-863, 1998.
15. Lindner, G., Botchkarev, V. A., Botchkareva, N. V., Ling, G., van der Veen, C., and Paus, R. Analysis of apoptosis during hair follicle regression (catagen) [see comments]. Am. J. Pathol., 151: 1601-1617, 1997.
16. Kinoshita, T., Yokota, T., Arai, K., and Miyajima, A. Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J., 14: 266-275, 1995.
17. Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. Bad, a heterodimeric partner for Bel-XL and Bcl-2, displaces Bax and promotes cell death. Cell, 80: 285-291, 1995.
18. Sedlak, T. W., Oltvai, Z. N., Yang, E., Wang, K., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA, 92: 7834-7838, 1995.
19. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) [see comments]. Cell, 87: 619-628, 1996.
20. Pena, J. C., Fuchs, E., and Thompson, C. B. Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. Cell Growth Differ., 8: 619-629, 1997.
21. Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., and Korsmeyer, S. J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88: 6961-6965, 1991.
22. Stenn, K. S., Lawrence, L., Veis, D., Korsmeyer, S., and Seiberg, M. Expression of the bcl-2 protooncogene in the cycling adult mouse hair follicle. J. Investig. Dermatol., 103: 107-111, 1994.
23. Krajewski, S., Krajewska, M., Shabaik, A., Miyashita, T., Wang, H. G., and Reed, J. C. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol., 145: 1323-1336, 1994.
24. Krajewski, S., Krajewska, M., Shabaik, A., Wang, H. G., Irie, S., Fong, L., and Reed, J. C. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res., 54: 5501-5507, 1994.
25. Krajewski, S., Krajewska, M., and Reed, J. C. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res., 56: 2849-2855, 1996.
26. Sayama, K., Yonehara, S., Watanabe, Y., and Miki, Y. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Investig. Dermatol., 103: 330-334, 1994.
27. Brysk, M. M., Selvanayagam, P., Arany, I., Brysk, H., Tyring, S. K., and Rajaraman, S. Induction of apoptotic nuclei by interferon-γ and by predesquamin in cultured keratinocytes. J. Interferon Cytokine Res., 15: 1029-1035, 1995.
28. Takahashi, H., Saitoh, K., Kishi, H., and Parsons, P. G. Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-KIT) in melanocytic tumours. Virchows Arch., 427: 283-288, 1995.
29. Breel, M., Laman, J., and Kraal, G. Murine hybrid cell lines expressing the NLDC-145 dendritic cell determinant. Immunobiology, 178: 167-176, 1988.
30. Swiggard, W. J., Mirza, A., Nussenzweig, M. C., and Steinman, R. M. DEC-205, a 205-kDa protein abundant on mouse dendritic cells and thymic epithelium that is detected by the monoclonal antibody NLDC-145: purification, characterization, and N-terminal amino acid sequence. Cell Immunol., 165: 302-311, 1995.
31. Hancock, G. E., Kaplan, G., and Conn, Z. A. Keratinocyte growth regulation by the products of immune cells. J. Exp. Med., 168: 1395-1402, 1988.
32. Noso, N., Sticherling, M., Bartels, J., Mallet, A. I., Christophers, E., and Schroder, J. M. Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts. J. Immunol., 156: 1946-1953, 1996.
33. Imokawa, G., Yada, Y., Kimura, M., and Morisaki, N. Granulocyte/ macrophage colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis. Biochem. J., 313: 625-631, 1996.
34. Amendt, C., Schirmacher, P., Weber, H., and Blessing, M. Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogere, 17: 25-34, 1998.
35. Lang, R. A., Metcalf, D., Cuthbertson, R. A., Lyons, I., Stanley, E., Kelso, A., Kannourakis, G., Williamson, D. J., Klintworth, G. K., Gonda, T. J., et al. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell, 51: 675-686, 1987.
36. Gearing, A. J., Metcalf, D., Moore, J. G., and Nicola, N. A. Elevated levels of GM-CSF and IL-1 in the serum, peritoneal and pleural cavities of GM-CSF transgenic mice. Immunology, 67: 216-220, 1989.
37. Metcalf, D., Elliott, M. J., and Nicola, N. A. The excess numbers of peritoneal macrophages in granulocyte-macrophage colony-stimulating factor transgenic mice are generated by local proliferation. J. Exp. Med., 175: 877-884, 1992.
38. Herbst, B., Kohler, G., Mackensen, A., Veelken, H., and Lindemann, A. GM-CSF promotes differentiation of a precursor cell of monocytes and Langerhans-type dendritic cells from CD34+ haemopoietic progenitor cells. Br. J. Haematol., 101: 231-241, 1998.
39. Damsgaard, T. E., Olesen, A. B., Sorensen, F. B., Thestrup-Pedersen, K., and Schiotz, P. O. Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin. Arch. Dermatol. Res., 289: 256-260, 1997.
40. Xing, Z., Tremblay, G. M., Sime, P. J., and Gauldie, J. Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-β1 and myofibroblast accumulation. Am. J. Pathol., 150: 209-222, 1997.
41. Cheng, J., Turksen, K., Yu, Q. C., Schreiber, H., Teng, M., and Fuchs, E. Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF α transgenic mice. Genes Dev., 6: 1444-1456, 1992.
42. Wang, X., Zinkel, S., Polonsky, K., and Fuchs, E. Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy. Proc. Natl. Acad. Sci. USA, 94: 219-226, 1997.
43. Potten, C. S. Epidermal transit times. Br. J. Dermatol., 93: 649-658, 1975.
44. Potten, C. S., Hume, W. J., and Parkinson, E. K. Migration and mitosis in the epidermis. Br. J. Dermatol., 111: 695-699, 1984.
45. Tao, W., Kurschner, C., and Morgan, J. I. Bcl-xS and Bad potentiate the death suppressing activities of Bcl-xL, Bcl-2, and A1 in yeast. J. Biol. Chem., 273: 23704-23708, 1998.
46. Tao, W., Kurschner, C., and Morgan, J. I. Modulation of cell death in yeast by the Bcl-2 family of proteins. J. Biol. Chem., 272: 15547-15552, 1997.
47. Lin, E. Y., Orlofsky, A., Berger, M. S., and Prystowsky, M. B. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol., 151: 1979-1988, 1993.
48. Takahashi, H., Kobayashi, H., Hashimoto, Y., Matsuo, S., and Iizuka, H. Interferon-γ-dependent stimulation of Fas antigen in SV40-transformed human keratinocytes: modulation of the apoptotic process by protein kinase C. J. Investig. Dermatol., 105: 810-815, 1995.
49. Gough, N. M., Gough, J., Metcalf, D., Kelso, A., Grail, D., Nicola, N. A., Burgess, A. W., and Dunn, A. R. Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor. Nature (Lond.), 309: 763-767, 1984.
50. Blessing, M., Nanney, L. B., King, L. E., Jones, C. M., and Hogan, B. L. Transgenic mice as a model to study the role of TGF-β-related molecules in hair follicles. Genes Dev., 7: 204-215, 1993.
51. Hogan, B. L. M., Costatini, F., and Lacy, E. Manipulating the Mouse Embryo. A Laboratory Manual, pp. 153-197. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986.
52. Casatorres, J., Navarro, J. M., Blessing, M., and Jorcano, J. L. Analysis of the control of expression and tissue specificity of the keratin 5 gene, characteristic of basal keratinocytes. Fundamental role of an AP-1 element. J. Biol. Chem., 269: 20489-20496, 1994.
53. Gitelman, S. E., Kobrin, M., Lee, A., Fet, V., Lyons, K., Hogan, B. L. M., and Derynck, R. Structure and sequence of the mouse Bmp6 gene. Calcif. Tissue Int., 60: 283-290, 1997.
54. Jorcano, J. L., Franz, J. K., and Franke, W. W. Amino acid sequence diversity between bovine epidermal cytokeratin polypeptides of the basic (type II) subfamily as determined from cDNA clones. Differentiation, 28: 155-163, 1984.
55. Jorcano, J. L., Rieger, M., Franz, J. K., Schiller, D. L., Moll, R., and Franke, W. W. Identification of two types of keratin polypeptides within the acidic cytokeratin subfamily I. J. Mol. Biol., 179: 257-281, 1984.
56. Kaiser, S., Schirmacher, P., Philipp, A., Protschka, M., Moll, I., Nicol, K., and Blessing, M. Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepithelialization and scar formation in BMP-6 overexpressing transgenic mice. J. Investig. Dermatol., 111: 1145-1152, 1998.
57. Howells, G. L., and Williams, D. M. Trie sequential demonstration of non-specific esterase reactivity la antigen and Thy-1 antigen in murine epidermal sheets. Arch. Oral Biol., 32: 679-683, 1987.
58. Becker, D., Reske-Kunz, A. B., Knop, J., and Reske, K. Biochemical properties of MHC class II molecules endogenously synthesized and expressed by mouse Langerhans cells. Eur. J. Immunol., 21: 1213-1220, 1991.
59. Blessing, M., Schirmacher, P., and Kaiser, S. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J. Cell Biol., 135: 227-239, 1996.
60. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
61. Tokunaga, K., Taniguchi, H., Yoda, K., Shimizu, M., and Sakiyama, S. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal β-actin mRNA. Nucleic Acids Res., 14: 2829, 1986.
62. Ulrich, E., Kauffmann-Zeh, A., Hueber, A. O., Williamson, J., Chittenden, T., Ma, A., and Evan, G. Gene structure, cDNA sequence, and expression of murine Bak, a proapoptotic Bcl-2 family member. Genomics, 44: 195-200, 1997.
63. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
64. Negrini, M., Silini, E., Kozak, C., Tsujimoto, Y., and Croce, C. M. Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell, 49: 455-463, 1987.
65. Gonzalez-Garcia, M., Perez-Ballestero, R., Ding, L., Duan, L., Boise, L. H., Thompson, C. B., and Nunez, G. bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development (Camb.), 120: 3033-3042, 1994.